Submitted via IRC for SoyCow1984
Drug companies are sitting on generics—43% of recently approved aren't for sale
Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
(Score: 4, Touché) by Thexalon on Sunday February 10 2019, @07:56PM (3 children)
I'm pretty sure between me and my engineering and construction buddies, we can build a functional guillotine. If things continue as they have for long enough, that's going to start looking like a pretty good option.
The only thing that stops a bad guy with a compiler is a good guy with a compiler.
(Score: 2) by coolgopher on Monday February 11 2019, @12:23AM
If you've got engineering buddies, go for a trebuchet, they're much more interesting ;)
(Score: 2) by Azuma Hazuki on Tuesday February 12 2019, @01:46AM (1 child)
Like so many other things, this is a problem of political will, not technology. Yes, you can build any number of guillotines; how do you get the guilty parties under the blade?
I am "that girl" your mother warned you about...
(Score: 2) by Thexalon on Tuesday February 12 2019, @02:26AM
There are thousands of us for every 1 of them, numbers will eventually tell.
The only thing that stops a bad guy with a compiler is a good guy with a compiler.